Nexalin Technology (NXL) Total Liabilities (2021 - 2026)
Nexalin Technology's (NXL) quarterly Total Liabilities came in at $808364.0 in Q1 2026, up 40.65% year-on-year from $574736.0 in Q1 2025, and down 8.9% quarter-over-quarter from $887333.0 in Q4 2025.
Nexalin Technology (NXL) Total Liabilities (2021 - 2026) Analysis & Trends
Nexalin Technology's Total Liabilities history runs 6 years deep, the most recent figure standing at $808364.0 for Q1 2026.
- On a quarterly basis, Total Liabilities rose 40.65% year-over-year to $808364.0 in Q1 2026; TTM through Mar 2026 was $808364.0, a 40.65% increase from a year earlier, with the FY2025 full-year figure at $887333.0, up 62.31% from the prior year.
- Total Liabilities eased to $808364.0 in Q1 2026 per NXL's latest filing, from $887333.0 in the prior quarter.
- Across five years, Total Liabilities topped out at $2.0 million in Q3 2022 and bottomed at $212104.0 in Q2 2024.
- The 5-year median for Total Liabilities is $600584.0 (2025), against an average of $849720.7.
- Across the five-year window, Total Liabilities plunged 82.06% in 2024 and jumped 183.16% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $2.0 million in 2022, then tumbled by 78.23% to $425281.0 in 2023, then increased by 28.55% to $546694.0 in 2024, then soared by 62.31% to $887333.0 in 2025, then declined by 8.9% to $808364.0 in 2026.
- Per Business Quant, the three latest NXL Total Liabilities figures stand at $808364.0 (Q1 2026), $887333.0 (Q4 2025), and $357524.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 808,364.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 808,364.00 |
| Dec 31, 2025 | 887,333.00 |
| Sep 30, 2025 | 357,524.00 |
| Jun 30, 2025 | 600,584.00 |
| Mar 31, 2025 | 574,736.00 |
| Dec 31, 2024 | 546,694.00 |
| Sep 30, 2024 | 299,389.00 |
| Jun 30, 2024 | 212,104.00 |
| Mar 31, 2024 | 507,223.00 |
| Dec 31, 2023 | 425,281.00 |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Dec 31, 2021 | 2.44 Mn |